Understanding the pathogenesis of SARS-CoV-2 encephalitis
In collaboration with an international team of scientists, HT researchers identified a missense mutation in a gene involved in brain-intrinsic immunity as the genetic cause of SARS-CoV-2 brainstem encephalitis. The findings are published in the Journal of Experimental Medicine.
Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) causes COVID-19, a respiratory illness responsible for the global COVID-19 pandemic in 2020. In addition to targeting the lungs where it produces severe respiratory problems, SARS‑CoV‑2 can enter the central nervous system, which includes the brain and the spinal cord, and lead to inflammation of the brain tissue or encephalitis.
The pathogenesis of SARS-CoV-2 encephalitis is poorly understood. To investigate the mechanisms of SARS-CoV-2 encephalitis, researchers from the Rockefeller University (USA), the Sloan Kettering Institute (USA), the University of Gothenburg (Sweden), Inserm, Paris (France), and the group of Oliver Harschnitz at Human Technopole (Italy), performed whole-exome/genome sequencing of 16 patients from the COVID Human Genetic Effort (www.covidhge.com) cohort who developed isolated encephalitis following acute SARS-CoV-2 infection. The sequencing allowed the researchers to identify a patient, a Swedish 14-year-old boy, carrying a missense mutation of the RNA lariat-debranching enzyme 1, DBR1(I120T).
DBR1 is highly expressed in the brainstem and spinal cord, where it removes byproducts of RNA splicing or lariats. DBR1 was previously reported as a genetic aetiology of brainstem viral encephalitis induced, for example, by Herpes Simplex Virus 1 (HSV-1), influenza B virus or norovirus. The I120T mutation is not deleterious per se but it lowers the protein level of DBR1 and thereby decreases RNA lariat-debranching activity.
The researchers found that fibroblasts from the patient contained low levels of DBR1 protein and high levels of RNA lariats. Similarly, DBR1 I120T/I120T hindbrain neurons generated from human pluripotent stem cells showed high levels of RNA lariats, which decreased when the wild-type version of DBR1 was overexpressed in such cells. Importantly, the team noticed that SARS-CoV-2 infection increased the levels of RNA lariats in both healthy and DBR1 I120T/I120T hindbrain neurons. Altogether, these findings suggest that SARS-CoV-2 infection is uncontrolled in DBR1-deficient hindbrain neurons due to the accumulation of RNA lariats.
“Our findings confirm that DBR1 is a gatekeeper of the human brainstem against several viruses, including not only HSV-1, influenza B virus, and norovirus, but also SARS-CoV-2. Patients with DBR1 deficiency should be vaccinated, not only against SARS-CoV-2, but probably also against a broader range of viruses”, the authors say.
Oliver Harschnitz, co-last author of the study, also commented “It will now be important to decipher the detailed molecular mechanisms by which the accumulation of intronic lariats impairs cell-intrinsic immunity to viruses in the brainstem. Such studies may pave the way for developing effective preventive or therapeutic measures for patients prone to brainstem encephalitis.”
Share:
You could also like:
-
AI Creates New ‘Alarm Bells’ for Prostate Cancer Recurrence
A study by Human Technopole, the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust in London has shown that in prostate cancer the presence in the same tumour of cells with large differences in shape and genetic composition indicates an increased risk of relapse, including after a decade. The study may help doctors better tailor treatment for this disease, adopting more aggressive therapies in cases where these parameters indicate a higher risk of disease recurrence.
-
HT’s “Open” Technologies for the Italian Scientific Community
Human Technopole is opening its National Facilities, providing advanced equipment and technologies accessible through calls for proposals open to the Italian scientific community. Projects will be selected by a commission of international experts. Scientists will have access to five new dedicated facilities, which act as catalysts for open innovation in the life sciences sector, crucial for research and the health of Italians.
-
Clearer microscopy images in spatial biology
An international team of scientists led by HT researchers Magda Bienko and Nicola Crosetto developed an open-source software for deconvolution of widefield fluorescence microscopy image stacks and large tissue scans. This new tool increases the information obtained with fluorescence microscopy-based spatial omic methods.
-
Genetics study points to potential treatments for restless leg syndrome
HT researchers are part of an international team of scientists that discovered genetic clues to the cause of restless leg syndrome, a condition common among older adults. The finding could help identify those individuals at greatest risk of the condition and point to potential ways to treat it.
-
4 PhD opportunities at HT through DADS
Human Technopole (HT) is glad to announce the availability of 4 new fully funded PhD positions in the fields of Health Data Science, Population and Medical Genomics and Computational Biology. These positions aim to attract highly motivated graduates with strong academic backgrounds who are interested in cutting-edge research in data science.